CFF Fluid Control IPO Opens July 9: Defence Tech Firm Launches ₹87.75 Crore Issue
NOOR MOHMMED
05/Jul/2025

-
CFF Fluid Control IPO opens July 9, 2025; ₹87.75 crore issue with BSE SME listing on July 16.
-
Defence-focused engineering firm with strong revenue and profit growth over three years.
-
High valuation at 51.45x P/E with no grey market premium; avoid for short-term listing gains.
CFF Fluid Control Ltd was established to deliver cutting-edge technology and engineering solutions to India’s defence sector.
Notably:
✅ Signed a Technology Transfer (TOT) agreement with Coyard SAS France early on.
✅ Supplies fluid control and mechanical equipment for the Indian Navy's submarine programme.
Their core focus on import substitution and high-spec engineering makes them a strategic player in India’s growing defence manufacturing ecosystem.
Promoter Background
-
Mr. Sunil Menon and Mr. Gautam Makker
-
30+ years of business experience
-
20+ years in defence sector-related projects
They have driven the company’s growth with their deep industry knowledge and government contract experience.
IPO Details
Particulars | Details |
---|---|
IPO Type | Fixed Price Issue |
Total Issue Size | ₹87.75 Crores |
Fresh Issue | ₹87.75 Crores (15.00 lakh shares) |
Offer for Sale | Nil |
Price | ₹585 per share |
IPO Opens | July 09, 2025 |
IPO Closes | July 11, 2025 |
Allotment Date | July 14, 2025 |
Listing Date | July 16, 2025 |
Exchange | BSE SME |
Market Capitalisation | ₹1,226.98 Crores (at issue price) |
Lot Size | 200 shares |
Retail Min Investment | ₹2,34,000 (2 lots = 400 shares) |
HNI Min Investment | ₹3,51,000 (3 lots = 600 shares) |
Financial Performance (₹ in Lakhs)
Fiscal Year | Revenue | EBITDA | Profit After Tax |
---|---|---|---|
FY25 | ₹14,609.79 | ₹4,130.94 | ₹2,385.03 |
FY24 | ₹10,697.57 | ₹3,085.38 | ₹1,708.78 |
FY23 | ₹7,109.94 | ₹1,882.82 | ₹1,013.60 |
✅ Consistent revenue growth ~33% CAGR
✅ EBITDA more than doubled in 3 years
✅ PAT grew ~2.4x over 3 years
Valuation Metrics
Metric | Value |
---|---|
Pre-Issue EPS (FY24) | ₹12.25 |
Post-Issue EPS (FY24) | ₹11.37 |
Pre-Issue P/E Ratio | 47.75x |
Post-Issue P/E Ratio | 51.45x |
Industry Average P/E | ~80x |
ROCE (FY24) | 21.84% |
ROE (FY24) | 17.42% |
RoNW | 16.13% |
⚖️ The IPO is fairly priced relative to its sector, but premium valuation (~51x P/E) limits listing gain potential.
GMP & Listing Prospects
GMP Status | Details |
---|---|
Grey Market Premium | ₹0 |
Expected Listing Gain | 0% |
Investor Sentiment | Weak for listing gains |
Note: No meaningful grey market activity indicates low demand for short-term flips.
Strengths
✅ Niche supplier to defence, a strategic sector with policy tailwinds
✅ Technology Transfer agreement with French OEM
✅ Strong 3-year revenue and profit CAGR
✅ Experienced promoter team with defence industry relationships
Risks & Concerns
⚠️ High issue price and valuation (51x P/E) limits upside
⚠️ Large minimum investment of ₹2.34 lakh (retail), limits access
⚠️ Dependent on defence contracts, which have long gestation and payment cycles
⚠️ SME listing can mean low liquidity post-listing
Expert Recommendation
Investor Type | Recommendation |
---|---|
Long-Term Investors | ⚠️ Cautious approach due to premium valuation |
Short-Term Traders | ❌ Avoid for listing gains (GMP at ₹0) |
Conservative Investors | ❌ Avoid |
Defence/Strategic Play Investors | ✅ Consider for sectoral exposure (long-term) |
Final Verdict
CFF Fluid Control IPO offers credible growth and a defence-sector moat with proven execution.
But at 51x P/E, it is expensive by SME IPO standards. With no grey market premium and a high retail ticket size, listing gain chances are minimal.
✅ Verdict: Avoid for listing gains.
⚖️ Long-term defence-focused investors may consider a small allocation if comfortable with risk.
Disclaimer:
This article is intended for informational and educational purposes only and does not constitute investment advice. Readers are advised to consult their financial advisor before making any investment decisions. Investments in securities are subject to market risks. Please read all related documents carefully before applying for the IPO. The data provided is based on publicly available information and may be subject to change.
The Upcoming IPOs in this week and coming weeks are Asston Pharmaceuticals, CFF Fluid Control, Smarten Power Systems, Glen Industries, Travel Food Services, Anthem Biosciences, Chemkart India.
The Current active IPO are Meta Infotech, Happy Square Outsourcing Services, Cryogenic OGS.
Start your Stock Market Journey and Apply in IPO by Opening Free Demat Account in Choice Broking FinX.
Join our Trading with CA Abhay Telegram Channel for regular Stock Market Trading and Investment Calls by CA Abhay Varn - SEBI Registered Research Analyst.